GlassScriptPhysician profile
Michael Hoenig
NPI 1912118035
$2,613.71
in general payments reported to CMS, 2019-2025
12 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $60.94 · 2021: $646 · 2022: $350 · 2023: $15.38 · 2024: $1,120 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $756 · Travel and Lodging: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $755.66 |
| Travel and Lodging | $637.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $962.41 | 2024 | Comprehensive Shoulder System, Comprehensive |
| Avanos Medical | $808.54 | 2020-2022 | |
| Abbott Laboratories | $202.38 | 2021-2024 | Proclaim |
| Vericel Corporation | $150.00 | 2025 | Maci |
| Wright Medical Technology, INC. | $113.98 | 2019 | |
| Anika Therapeutics, INC. | $107.85 | 2025 | Tactoset, Integrity Implant |
| Linvatec Corporation | $94.05 | 2024 | Biobrace 23mm, Linvatec Shoulder Arthroscopy, Linvatec Hip Preservation System |
| Horizon Therapeutics Plc | $52.02 | 2019-2022 | |
| Ermi LLC | $49.26 | 2019-2020 | |
| Inari Medical, INC. | $40.92 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Osiris Therapeutics INC. | $16.86 | 2019 | |
| Abbvie INC. | $15.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoenig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.